We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Industry

Image: The global hemostasis analyzers market is expected to reach close to USD 6 billion in 2026 (Photo courtesy of Pexels)

Global Hemostasis Analyzers Market Driven by Increasing Awareness of Blood Disorder Conditions

The global hemostasis analyzers market is expected to reach USD 5.97 billion in 2026, driven by the increasing awareness of blood disorder conditions such as Hemophilia and Von Willebrand disease (vWD) which are genetic disorders and not well known to people. This results in late diagnosis of blood disorders and affects patient outcomes. The increasing awareness is expected to improve the diagnosis rate of blood disorders, thereby driving the demand for hemostasis analyzers. More...
09 Feb 2023
Image: The DPP Micro Reader II streamlines the point-of-care testing experience (Photo courtesy of Chembio)

Chembio and Biosynex to Merge, Forging US-French Point-of-Care Testing Powerhouse

Biosynex SA, a French company specializing in the design and distribution of rapid tests, and Chembio Diagnostics, Inc., a leading point-of-care diagnostics company in the U.S. that is focused on infectious diseases, have entered into a definitive merger agreement under which Biosynex, through a subsidiary, will acquire Chembio in an all-cash transaction valued at USD 17.2 million. More...
02 Feb 2023
Image: The ‘More than Diagnostics’ campaign expresses the company’s ambition to continue growing and advancing towards an exciting future (Photo courtesy of CerTest)

CerTest to Run ‘More than Diagnostics’ Campaign Throughout 2023

CerTest Biotec has announced that the company will run its campaign ‘More than Diagnostics’ throughout 2023 in acknowledgement of the transformation that it has gone through, accelerated by the COVID-19 pandemic. CerTest’s ‘More than Diagnostics’ campaign expresses the company’s ambition to continue growing and advancing towards an exciting future, with people’s health remaining its key focus. More...
01 Feb 2023
Image: Digital pathology opens up new possibilities and offers advanced tools for pathologists (Photo courtesy of Paige)

New Collaboration to Apply Power of AI to Digital Pathology Images

Clinical artificial intelligence (AI) applications have the potential to help pathologists diagnose cancer more confidently and efficiently, ultimately improving patient care. Now, a new collaboration aims to lead the digital transformation of pathology and cancer diagnosis. More...
30 Jan 2023
Image: The global point-of-care glucose testing market is expected to reach close to USD 6 billion by 2032 (Photo courtesy of Pexels)

Point-of-Care Glucose Testing Market to Reach Almost USD 6 Billion by 2032

The global point-of-care (POC) glucose testing market is projected to register a CAGR of 4.3% during the forecast period from 2022 to 2032 to reach USD 5.8 billion by 2032, driven by a rise in the geriatric population, speed & precision of POC screening, increased adoption of electronic medical information, and the higher risk of COVID-19-related mortality associated with diabetes. More...
25 Jan 2023
Image: DZ-Lite c270 Benchtop Chemistry Analyzer (Photo courtesy of Carolina Liquid Chemistries)

Carolina Liquid Chemistries and Diazyme Enter Into Partnership

Carolina Liquid Chemistries, Corp. (CLC, Greensboro, NC, USA) and Diazyme Laboratories, Inc. (San Diego, CA, USA) have entered into a partnership to expand the test menu on the Diazyme DZ-Lite c270 benchtop clinical chemistry analyzer, allowing it to run both special and routine chemistries. More...
24 Jan 2023
Image: The laboratory equipment R&D center launched in Swords, Ireland will explore breakthrough healthcare innovations (Photo courtesy of Siemens)

Siemens Launches Centre of Excellence for Immunoassay Instrument R&D in Ireland

Siemens Healthineers has launched a Center of Excellence for Immunoassay Instrument Research and Development (R&D) in Swords, Ireland. The new center will focus on unlocking breakthrough innovations in laboratory instruments used to detect infectious diseases, cancer and blood disorders. More...
23 Jan 2023
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2025 Globetech Media. All rights reserved.